Stephan Jackman
Chief Executive Officer bei ALZAMEND NEURO, INC.
Vermögen: 3 033 $ am 31.03.2024
Profil
Stephan Jackman is currently the Chief Executive Officer & Director at Alzamend Neuro, Inc. He previously served as the Chief Operating Officer at Ennaid Therapeutics LLC from 2015 to 2017 and at Exit 9 Technologies, Inc. from 2017 to 2018.
Mr. Jackman received his undergraduate and graduate degrees from Stevens Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALZAMEND NEURO, INC.
0,04% | 24.08.2023 | 3 033 ( 0,04% ) | 3 033 $ | 31.03.2024 |
Aktive Positionen von Stephan Jackman
| Unternehmen | Position | Beginn |
|---|---|---|
| ALZAMEND NEURO, INC. | Chief Executive Officer | 20.11.2018 |
Ehemalige bekannte Positionen von Stephan Jackman
| Unternehmen | Position | Ende |
|---|---|---|
| Exit 9 Technologies, Inc. | Chief Operating Officer | 01.11.2018 |
Ennaid Therapeutics LLC
 Ennaid Therapeutics LLC BiotechnologyHealth Technology Ennaid Therapeutics LLC develops orally deliverable anti-viral peptide that treats and prevents Zika virus. The company was founded by Darnisha Grant Harrison in 2012 and is headquartered in Alpharetta, GA. | Chief Operating Officer | 01.10.2017 |
Ausbildung von Stephan Jackman
| Stevens Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALZAMEND NEURO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ennaid Therapeutics LLC
Ennaid Therapeutics LLC BiotechnologyHealth Technology Ennaid Therapeutics LLC develops orally deliverable anti-viral peptide that treats and prevents Zika virus. The company was founded by Darnisha Grant Harrison in 2012 and is headquartered in Alpharetta, GA. | Health Technology |
| Exit 9 Technologies, Inc. |
